Chinese biopharma firm CStone gets $150m Series A from Oriza, Boyu, WuXi

Chinese biopharma firm CStone gets $150m Series A from Oriza, Boyu, WuXi

Boyu CapitalCStone PharmaceuticalsOriza Seed Venture CapitalWuXi Healthcare Ventures

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.